Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 4
2004 2
2005 2
2006 4
2007 1
2008 4
2009 4
2010 3
2011 3
2012 1
2013 1
2014 3
2015 3
2016 3
2017 3
2018 3
2019 4
2020 7
2021 3
2022 4
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Results by year

Filters applied: . Clear all
Page 1
Hematologic toxicities of chemotherapy in breast and ovarian cancer patients carrying BRCA1/BRCA2 germline pathogenic variants. A single center experience and review of the literature.
Hu-Heimgartner K, Lang N, Ayme A, Ming C, Combes JD, Chappuis VN, Vazquez C, Friedlaender A, Vuilleumier A, Bodmer A, Viassolo V, Sandoval JL, Chappuis PO, Labidi-Galy SI. Hu-Heimgartner K, et al. Among authors: chappuis po. Fam Cancer. 2023 Jul;22(3):283-289. doi: 10.1007/s10689-023-00331-6. Epub 2023 Apr 29. Fam Cancer. 2023. PMID: 37119509 Free PMC article. Review.
A new bioinformatics tool to help assess the significance of BRCA1 variants.
Cusin I, Teixeira D, Zahn-Zabal M, Rech de Laval V, Gleizes A, Viassolo V, Chappuis PO, Hutter P, Bairoch A, Gaudet P. Cusin I, et al. Among authors: chappuis po. Hum Genomics. 2018 Jul 11;12(1):36. doi: 10.1186/s40246-018-0168-0. Hum Genomics. 2018. PMID: 29996917 Free PMC article.
Relatives from Hereditary Breast and Ovarian Cancer and Lynch Syndrome Families Forgoing Genetic Testing: Findings from the Swiss CASCADE Cohort.
Sarki M, Ming C, Aceti M, Fink G, Aissaoui S, Bürki N, Graffeo R, Heinimann K, Caiata Zufferey M, Monnerat C, Rabaglio M, Zürrer-Härdi U, Chappuis PO, Katapodi MC, The Cascade Consortium. Sarki M, et al. Among authors: chappuis po. J Pers Med. 2022 Oct 19;12(10):1740. doi: 10.3390/jpm12101740. J Pers Med. 2022. PMID: 36294879 Free PMC article.
The Communication Chain of Genetic Risk: Analyses of Narrative Data Exploring Proband-Provider and Proband-Family Communication in Hereditary Breast and Ovarian Cancer.
Pedrazzani C, Aceti M, Schweighoffer R, Kaiser-Grolimund A, Bürki N, Chappuis PO, Graffeo R, Monnerat C, Pagani O, Rabaglio M, Katapodi MC, Caiata-Zufferey M. Pedrazzani C, et al. Among authors: chappuis po. J Pers Med. 2022 Jul 29;12(8):1249. doi: 10.3390/jpm12081249. J Pers Med. 2022. PMID: 36013197 Free PMC article.
Intention to Inform Relatives, Rates of Cascade Testing, and Preference for Patient-Mediated Communication in Families Concerned with Hereditary Breast and Ovarian Cancer and Lynch Syndrome: The Swiss CASCADE Cohort.
Sarki M, Ming C, Aissaoui S, Bürki N, Caiata-Zufferey M, Erlanger TE, Graffeo-Galbiati R, Heinimann K, Heinzelmann-Schwarz V, Monnerat C, Probst-Hensch N, Rabaglio M, Zürrer-Härdi U, Chappuis PO, Katapodi MC, On Behalf Of The Cascade Consortium. Sarki M, et al. Cancers (Basel). 2022 Mar 23;14(7):1636. doi: 10.3390/cancers14071636. Cancers (Basel). 2022. PMID: 35406409 Free PMC article.
Durable response to palbociclib and letrozole in ovarian cancer with CDKN2A loss.
Frisone D, Charrier M, Clement S, Christinat Y, Thouvenin L, Homicsko K, Michielin O, Bodmer A, Chappuis PO, McKee TA, Tsantoulis P. Frisone D, et al. Among authors: chappuis po. Cancer Biol Ther. 2020;21(3):197-202. doi: 10.1080/15384047.2019.1685291. Epub 2019 Nov 10. Cancer Biol Ther. 2020. PMID: 31709901 Free PMC article.
59 results